ArticleDiscover oncology2026
Causal association between Epstein-Barr virus infection and malignant gynecologic and breast tumors: a two-sample Mendelian randomization study.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo explore the causal association between genetically predicted Epstein–Barr virus (EBV) infection and breast, cervical, endometrial, and ovarian cancers.
methodsPublic data from genome-wide association studies of EBV infection and cancers were used to perform a two-sample Mendelian randomization (MR) study. The inverse variance weighted (IVW) method was the main analysis method, while the weighted median, weighted mode, and MR-Egger methods were used to test the robustness of the IVW results. Cochran’s Q-test, MR-Egger regression, MR-PRESSO, and leave-one-out methods were used to detect heterogeneity, horizontal pleiotropy, outliers, and SNPs driving the results, respectively.
resultsThere were no statistically significant causal associations between genetically predicted EBV infection and genetically predicted endometrial (OR = 1.55, 95%CI: 0.71–3.37, P = 0.27), cervical (OR = 0.96, 95%CI: 0.42–2.22, P = 0.93), ovarian (OR = 1.55, 95%CI: 0.72–3.33, P = 0.26), or breast (OR = 1.02, 95%CI: 0.79–1.33, P = 0.85) cancers. The raw MR-PRESSO analyses support the IVW results but detected one outlier for the endometrial cancer analysis. After removing the outlier, a suggestive association was observed between EBV infection and endometrial cancer (OR = 2.43, 95%CI: 1.19–4.95, P = 0.024). Cochran’s Q-test detected heterogeneity for endometrial cancer (P = 0.04). The MR-Egger regression analysis revealed no horizontal pleiotropy. The leave-one-out analysis revealed no SNPs driving the results by themselves.
conclusionsThis MR study showed a possible causal association between EBV infection and the risk of endometrial cancer. This association warrants additional study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.